Osteoprotegerin (OPG, Osteoclastogenesis Inhibitory Factor, OCIF) Recombinant, Human

Catalog No : USB-O8065-01
354.03€
0.00€

Shipping cost plus VAT not included , delivery in 7-14 business days

Product name Osteoprotegerin (OPG, Osteoclastogenesis Inhibitory Factor, OCIF) Recombinant, Human
Catalog No USB-O8065-01
Supplier’s Catalog No O8065-01
Supplier US Biologicals
Source antigen Recombinant, E. coli
Reactivity
Cross reactivity
Applications
Molecular weight
Storage -20°C
Other names
Grade Molecular Biology Grade
Purity ≥98% by SDS-PAGE and HPLC. Endotoxin: ≤0.1ng/ug (1EU/ug).
Form Supplied as a lyophilized powder from 10mM Tris, pH7.5, 75mM sodium chloride. Reconstitute with 5mM Tris, pH 7.5, to a concentration of 0.1-1mg/ml. Do not vortex. For long term storage add a carrier protein (0.1% BSA).
Reactivity life 6 months
Note For reserch purpose only
Purity ≥98% by SDS-PAGE and HPLC. Endotoxin: ≤0.1ng/ug (1EU/ug).
Description Human OPG (Osteoprotegerin, also know as OCIF Osteoclastogenesis inhibitory factor), is a member of the TNF receptor superfamily. Recombinant human OPG/OCIF specifically acts on bone tissues and increases bone mineral density and bone volume associated with a decrease of active osteoclast number. Recombinant human OPG is a 19.9kD protein, containing 175 amino acid residues, comprising the extra-cellular domain of OPG. Amino Acid Sequence: METFPPKYLH YDEETSHQLL CDKCPPGTYL KQHCTAKWKT VCAPCPDHYY TDSWHTSDEC LYCSPVCKEL QYVKQECNRT HNRVCECKEG RYLEIEFCLK HRSCPPGFGV VQAGTPERNT VCKRCPDGFF SNETSSKAPC RKHTNCSVFG LLLTQKGNAT HDNICSGNSE STQK Biological Activity: Determined by its ability to neutralize the stimulation of U937 cells treated with 10ng/ml of soluble RANKL (sRANKL). Storage and Stability: Lyophilized powder may be stored at -20°C. Stable for 12 months after receipt at -20°C. Reconstitute with sterile buffer. For long term storage add a carrier protein (0.1% BSA). Aliquot to avoid repeated freezing and thawing. Store at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.